[go: up one dir, main page]

NO20020132L - Legemiddel med beskyttende virkning mot oksidativ-toksiske stoffer, s¶rlig mot kardiotoksiske stoffer - Google Patents

Legemiddel med beskyttende virkning mot oksidativ-toksiske stoffer, s¶rlig mot kardiotoksiske stoffer

Info

Publication number
NO20020132L
NO20020132L NO20020132A NO20020132A NO20020132L NO 20020132 L NO20020132 L NO 20020132L NO 20020132 A NO20020132 A NO 20020132A NO 20020132 A NO20020132 A NO 20020132A NO 20020132 L NO20020132 L NO 20020132L
Authority
NO
Norway
Prior art keywords
substances
protective effect
medicinal product
cardiotoxic
toxic substances
Prior art date
Application number
NO20020132A
Other languages
English (en)
Other versions
NO20020132D0 (no
NO329558B1 (no
Inventor
Susanna Rozsa
Julius Gy Papp
Dirk Thormaehlen
Harald Waldeck
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO20020132D0 publication Critical patent/NO20020132D0/no
Publication of NO20020132L publication Critical patent/NO20020132L/no
Publication of NO329558B1 publication Critical patent/NO329558B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20020132A 1999-07-13 2002-01-11 Anvendelse av benzazepin-N-eddiksyrederivater til fremstilling av farmasoytiske preparater for profylakse og/eller hjelpebehandling av hjerteskader, samt produkter som kombinasjonspreparater som inneholder slike forbindelser NO329558B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19932555A DE19932555A1 (de) 1999-07-13 1999-07-13 Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
PCT/EP2000/006525 WO2001003699A1 (de) 1999-07-13 2000-07-10 Arzneimittel mit protektiver wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische substanzen

Publications (3)

Publication Number Publication Date
NO20020132D0 NO20020132D0 (no) 2002-01-11
NO20020132L true NO20020132L (no) 2002-03-12
NO329558B1 NO329558B1 (no) 2010-11-15

Family

ID=7914519

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020132A NO329558B1 (no) 1999-07-13 2002-01-11 Anvendelse av benzazepin-N-eddiksyrederivater til fremstilling av farmasoytiske preparater for profylakse og/eller hjelpebehandling av hjerteskader, samt produkter som kombinasjonspreparater som inneholder slike forbindelser

Country Status (28)

Country Link
US (1) US6906059B2 (no)
EP (1) EP1200095B1 (no)
JP (1) JP4824235B2 (no)
KR (1) KR100738940B1 (no)
CN (1) CN1267099C (no)
AR (1) AR024476A1 (no)
AT (1) ATE306926T1 (no)
AU (1) AU782733B2 (no)
BR (1) BR0012442A (no)
CA (1) CA2377904C (no)
CZ (1) CZ299070B6 (no)
DE (2) DE19932555A1 (no)
DK (1) DK1200095T3 (no)
ES (1) ES2246874T3 (no)
HK (1) HK1049116B (no)
HU (1) HUP0202424A3 (no)
IL (2) IL147604A0 (no)
MX (1) MXPA02000411A (no)
NO (1) NO329558B1 (no)
NZ (1) NZ517130A (no)
PL (1) PL198723B1 (no)
RU (1) RU2268727C2 (no)
SK (1) SK286020B6 (no)
TR (1) TR200200053T2 (no)
TW (1) TWI280880B (no)
UA (1) UA73134C2 (no)
WO (1) WO2001003699A1 (no)
ZA (1) ZA200200265B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
PL367093A1 (en) * 2001-05-18 2005-02-21 Solvay Pharmaceuticals Gmbh Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
PT1448567E (pt) * 2001-09-10 2010-03-12 Tibotec Pharm Ltd Método de preparação de hexa-hidro-furo[2,3-b]furan-3-ol
MXPA04006887A (es) 2002-01-16 2004-12-06 Solvay Pharm Bv Sales solidas de compuestos de benzazepina y su uso en la preparacion de compuestos farmaceuticos.
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
EP1687006B1 (en) * 2003-11-18 2007-11-14 Solvay Pharmaceuticals GmbH Pharmaceutical compositions for the treatment of renal dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
AU2005315608B2 (en) 2004-12-15 2011-03-31 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
EP1996939B1 (en) * 2006-02-27 2014-03-26 Targeted Molecular Diagnostics, LLC Methods for predicting cardiac toxicity before and upon treatment with tyrosine kinase inhibitors
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US20070292503A1 (en) * 2006-06-16 2007-12-20 Gorissen Henricus R Oral pharmaceutical composition of poorly water-soluble active substance
US20070299054A1 (en) * 2006-06-22 2007-12-27 Rajesh Jain Oral pharmaceutical composition of a poorly water-soluble active agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
ES2198418T3 (es) * 1993-07-21 2004-02-01 Yamanouchi Pharmaceutical Co. Ltd. Derivado de la benzazepina de fusion y composicion farmaceutica que incluye este derivado.
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
JP3775780B2 (ja) * 1997-09-18 2006-05-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 薬剤の経口的バイオアベイラビリテイを向上させるための縮合イミダゾール誘導体
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen

Also Published As

Publication number Publication date
IL147604A (en) 2006-12-31
CA2377904C (en) 2009-03-24
AR024476A1 (es) 2002-10-02
CZ200252A3 (cs) 2002-08-14
HUP0202424A3 (en) 2003-03-28
HK1049116B (zh) 2006-12-08
ES2246874T3 (es) 2006-03-01
CN1373666A (zh) 2002-10-09
AU782733B2 (en) 2005-08-25
IL147604A0 (en) 2002-08-14
NO20020132D0 (no) 2002-01-11
NZ517130A (en) 2004-10-29
JP2003504336A (ja) 2003-02-04
US6906059B2 (en) 2005-06-14
EP1200095B1 (de) 2005-10-19
DE19932555A1 (de) 2001-01-18
TR200200053T2 (tr) 2002-05-21
US20030040512A1 (en) 2003-02-27
NO329558B1 (no) 2010-11-15
PL198723B1 (pl) 2008-07-31
KR100738940B1 (ko) 2007-07-12
JP4824235B2 (ja) 2011-11-30
TWI280880B (en) 2007-05-11
SK286020B6 (sk) 2008-01-07
HK1049116A1 (en) 2003-05-02
WO2001003699A1 (de) 2001-01-18
CN1267099C (zh) 2006-08-02
AU6157200A (en) 2001-01-30
EP1200095A1 (de) 2002-05-02
HUP0202424A2 (hu) 2002-11-28
DE50011388D1 (de) 2006-03-02
CZ299070B6 (cs) 2008-04-16
ZA200200265B (en) 2003-03-26
SK142002A3 (en) 2002-06-04
RU2268727C2 (ru) 2006-01-27
MXPA02000411A (es) 2002-07-02
UA73134C2 (en) 2005-06-15
ATE306926T1 (de) 2005-11-15
KR20020019514A (ko) 2002-03-12
PL353012A1 (en) 2003-10-06
DK1200095T3 (da) 2005-11-14
BR0012442A (pt) 2002-04-02
CA2377904A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
NO20020132L (no) Legemiddel med beskyttende virkning mot oksidativ-toksiske stoffer, s¶rlig mot kardiotoksiske stoffer
SI1572707T1 (sl) Novi aromatski fluorglikozidni derivati, farmacevtski proizvodi, ki vsebujejo te spojine, in njihova uporaba
FR2796561B1 (fr) Seringue de securite
DE60003178D1 (de) Biostabile polyurethanprodukte
MXPA02001508A (es) Derivados de arilmetil-carbonilamino-tiazol y sus usos como agentes antitumorales.
DE60037203D1 (de) Medikamentenspender
IL144637A0 (en) Diaryl derivatives and their use as medicaments
ATE264680T1 (de) Beta-carbolin arzneistoffprodukte
PT1191865E (pt) Cartucho de produto alimentar
DE60033635D1 (de) Stimmgabelumdrehungsmesser
FI20000976A7 (fi) Tuotteita
NO20021838L (no) Energirikt n¶ringsmiddelprodukt
EE200100445A (et) Suitsetatav toode
SK2926U (sk) Mäsový výrobok
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
FR2799945B1 (fr) Broyeur alimentaire
DZ2159A1 (fr) Produits pharmaceutiques.
DE59907648D1 (de) Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
AU1412901A (en) Benzene derivatives and use thereof as drugs
ES1040746Y (es) Bolsa perfeccionada para el envasado de productos agricolas, hortofruticolas y similares.
FI19991726L (fi) Tukosvahti kuljettimen yhteydessä
DK50598A (da) Sikkerhedsdispenser for levnedsmidler
DK199900167U3 (da) Indikator integreret i fødevareemballage, medicinalvarer, m.v.
IT246565Y1 (it) Carrozzina con protezione variabile per bambini
SE9904282D0 (sv) Dietary product

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees